Skip to the content

ParValue.app

  • Pusher (*beta)
  • Tables (*beta)
  • News
  • Pusher (*beta)
  • Tables (*beta)
  • News

Year

2026

  • XOMA – 8-K

    18 Mar
  • UMH – 8-K

    18 Mar
  • NEE – FWP

    18 Mar
  • AGM – 8-K

    18 Mar
  • Predictiv AI Launches AGORACOM Marketing Program and Engages Venture Liquidity Partners for Market Making

    18 Mar
  • Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

    18 Mar
  • Meta Establishes New York City Retail Flagship at Vornado Realty Trust’s 697 Fifth Avenue

    18 Mar
  • Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

    18 Mar
  • TWO – 425

    18 Mar
  • TWO – 425

    18 Mar
  • Meta Establishes New York City Retail Flagship at Vornado Realty Trust’s 697 Fifth Avenue

    18 Mar
  • Truist announces first quarter 2026 earnings call details

    18 Mar
  • Truist announces first quarter 2026 earnings call details

    18 Mar
  • Fifth Third Recognized Among World’s Most Ethical Companies® by Ethisphere for the Seventh Year

    18 Mar
  • Fifth Third Recognized Among World’s Most Ethical Companies® by Ethisphere for the Seventh Year

    18 Mar
  • S2G Investments Appoints Brian O’Connor as Managing Director and Co-Head of Special Opportunities Strategy

    18 Mar
  • Kain Capital Expands Investment and Strategy Leadership with Hiring of Sameer Mathur as Partner and Bridie Gahan as Vice President of Strategy

    18 Mar
  • CareCloud Unveils Next-Generation MAP App at HFMA Revenue Cycle Conference

    18 Mar
  • Banks Strengthen Mobile Account Opening and Debit Card Controls While Delegated Access Emerges for Retail Customers to Safeguard Vulnerable Populations

    18 Mar
  • Brookfield Corporation Completes Annual Filings

    18 Mar
  • Brookfield Corporation Completes Annual Filings

    18 Mar
  • Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting

    18 Mar
  • AT&T Launches New App to Simplify Customers’ Digital Experience

    18 Mar
  • Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease

    18 Mar
  • Chronograph Hires Former Macquarie Portfolio Manager in Client Development Expansion

    18 Mar

Newer

Older

Privacy policy

Nothing on this site should be in any way construed as investment advice or a recommendation to buy or sell any security. Or do anything whatsoever. Any information posted on the site may be incorrect or incomplete.

Theme by Anders Norén